Fig. 2From: Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experimentsUPLC-PDA chromatogram analysis of the active compounds in ADI. A chromatograms of standard solution; B chromatograms of ADI sample solution. 1, Cantharidin; 2, Calycosin-7-glucoside; 3, Chlorogenic acid; 4, Isofraxidin; 5, Formononetin; 6, Astragaloside IV; 7, Astragaloside IBack to article page